Kyndryl (NYSE:KD) has been upgraded to a “Buy” rating by Wall Street Zen researchers. However, the overall analyst consensus for Kyndryl remains “Hold” with an average price target of $29.00, due to mixed sentiment including several recent downgrades and a “Strong Sell” rating from Zacks. The company faces significant challenges, including disclosed material internal-control weaknesses, ongoing securities class actions following a ~55% share plunge, and a recent earnings miss for its quarterly results.
This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
Kyndryl (NYSE:KD) Upgraded to "Buy" at Wall Street Zen
Kyndryl (NYSE:KD) has been upgraded to a “Buy” rating by Wall Street Zen researchers. However, the overall analyst consensus for Kyndryl remains “Hold” with an average price target of $29.00, due to mixed sentiment including several recent downgrades and a “Strong Sell” rating from Zacks. The company faces significant challenges, including disclosed material internal-control weaknesses, ongoing securities class actions following a ~55% share plunge, and a recent earnings miss for its quarterly results.